EUVIMEDEUVIMED entdecken
Open Access

Naloxone and Clinical Outcomes in Suspected Opioid-Associated Out-of-Hospital Cardiac Arrests

Ralph C Wang, Jake Toy, Juan Carlos C Montoy, Juliana Tolles, Paul F Ehlers, J Joelle Donofrio-Odmann, James J Menegazzi, Marianne Gausche-Hill, Robert M Rodriguez, David G Dillon, CAL-ROC Investigators

JAMA Network Open · 29.05.2026 · 9 (5) · e2615539

DOI: 10.1001/jamanetworkopen.2026.15539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 29.05.2026. Verfasst von Ralph C Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University of California, San Francisco. Hauptthemen laut MEDLINE: Naloxone, Out-of-Hospital Cardiac Arrest, Narcotic Antagonists, Opiate Overdose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Although US opioid overdose deaths have recently declined, mortality remains higher than before the COVID-19 pandemic, and the role of naloxone in opioid-associated out-of-hospital cardiac arrest (OA-OHCA) remains uncertain. The American Heart Association has identified a critical evidence gap regarding the role of naloxone in resuscitation care.

Objective

To assess the association between naloxone administered by emergency medical services (EMS) clinicians and outcomes in patients with suspected OA-OHCA. Design, Setting, and Participants This retrospective cohort study of adults (aged ≥18 years) with EMS-treated OHCA used data from the California Resuscitation Outcomes Consortium from January 1, 2021, to December 31, 2022. The primary cohort was patients with OA-OHCA, identified using the Naloxone Cardiac Arrest Decision Instrument (NACARDI) as age younger than 50 years and unwitnessed cardiac arrest. Additional analyses were conducted in patients with EMS-presumed drug-related OHCA and all patients with OHCA. Data were analyzed between November 2024 and July 2025. Exposure Naloxone administration during EMS resuscitation. Main Outcomes and Measures The primary outcome was survival to hospital discharge. Secondary outcomes were favorable neurologic outcome and return of spontaneous circulation (ROSC). Inverse probability weighted regression was used to estimate naloxone treatment effects as absolute risk differences (ARDs).

Results

Among 3811 patients meeting NACARDI criteria (median patient age, 37 years [IQR, 30-43 years]; 2792 [73.3%] male), 1251 (32.8%) received naloxone and 2560 (67.2%) did not. Survival to hospital discharge occurred in 101 patients (8.1%) who received naloxone vs 112 (4.4%) who did not. Favorable neurologic outcome occurred in 92 (7.4%) vs 84 (3.3%) and sustained ROSC in 177 (14.1%) vs 245 (9.6%), respectively. After adjustment for patient, OHCA incident, and agency-level factors, naloxone was associated with improved survival to hospital discharge (ARD, 2.75 percentage points [pp]; 95% CI, 1.25 to 4.26 pp), favorable neurologic outcome (ARD, 3.18 pp; 95% CI, 1.79 to 4.57 pp), and sustained ROSC (ARD, 3.27 pp; 95% CI, 1.11 to 5.43 pp). In sensitivity analyses of patients who received epinephrine, naloxone was not associated with improved survival to hospital discharge (adjusted ARD, 0.31 pp; 95% CI, −0.09 to 1.58 pp) or the other clinical outcomes. Conclusions and Relevance In this cohort study, among patients with suspected OA-OHCA, EMS-administered naloxone was associated with improved survival and neurologic status and sustained ROSC. These findings support the need for a randomized trial to assess the effects of naloxone in opioid-associated cardiac arrest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaloxoneOut-of-Hospital Cardiac ArrestNarcotic AntagonistsOpiate OverdoseHumansRetrospective StudiesMaleFemaleMiddle AgedEmergency Medical ServicesCaliforniaAdultCardiopulmonary ResuscitationTreatment Outcome

Substanzen

NaloxoneNarcotic Antagonists

Autor:innen und Institutionen

  • Department of Emergency Medicine, University of California, San Francisco.
  • Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California.
  • The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California.
  • Los Angeles County Emergency Medical Services Agency, Santa Fe Springs, California.
  • David Geffen School of Medicine at UCLA, Los Angeles, California.
  • California Poison Control System, San Francisco Division, San Francisco, California.

Zitieren

APA

Wang, R. C., Toy, J., Montoy, J. C. C., Tolles, J., Ehlers, P. F., Donofrio-Odmann, J. J., Menegazzi, J. J., Gausche-Hill, M., Rodriguez, R. M., Dillon, D. G., & CAL-ROC Investigators (2026). Naloxone and Clinical Outcomes in Suspected Opioid-Associated Out-of-Hospital Cardiac Arrests. JAMA Network Open, 9(5), e2615539. https://doi.org/10.1001/jamanetworkopen.2026.15539

Vancouver

Wang RC, Toy J, Montoy JCC, Tolles J, Ehlers PF, Donofrio-Odmann JJ, et al. Naloxone and Clinical Outcomes in Suspected Opioid-Associated Out-of-Hospital Cardiac Arrests. JAMA Network Open. 2026;9(5):e2615539. doi:10.1001/jamanetworkopen.2026.15539

BibTeX
@article{Wang2026,
  author = {Wang, Ralph C and Toy, Jake and Montoy, Juan Carlos C and Tolles, Juliana and Ehlers, Paul F and Donofrio-Odmann, J Joelle and Menegazzi, James J and Gausche-Hill, Marianne and Rodriguez, Robert M and Dillon, David G and CAL-ROC Investigators, CAL-ROC Investigators},
  title = {Naloxone and Clinical Outcomes in Suspected Opioid-Associated Out-of-Hospital Cardiac Arrests},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {5},
  pages = {e2615539},
  doi = {10.1001/jamanetworkopen.2026.15539}
}
Kostenlos starten →